Abstract
Patients with metastatic breast cancer should be offered comprehensive and personalized medical attention including, but not limited to, psychosocial, supportive and symptom-related interventions. A large number of treatment options are available and several prognostic and predictive factors are useful to identify the best therapeutic options individually.
MeSH terms
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Bone Neoplasms / secondary
-
Bone Neoplasms / therapy
-
Breast Neoplasms / genetics
-
Breast Neoplasms / pathology*
-
Breast Neoplasms / therapy*
-
Central Nervous System Neoplasms / secondary
-
Central Nervous System Neoplasms / therapy
-
Chemotherapy, Adjuvant
-
Female
-
Genes, erbB-2
-
Humans
-
Neoadjuvant Therapy
-
Neoplasm Metastasis
-
Postmenopause
-
Receptors, Estrogen / genetics
-
Recurrence
Substances
-
Antineoplastic Agents, Hormonal
-
Receptors, Estrogen